Description
Gastric Bands Market growing at a CAGR of 4.3% from 2022 to 2028. The global market provides a detailed overview and that can be segmented by product type and by end user. By product type, the global gastric bands market has been segmented into Adjustable Gastric Bands and Non-Adjustable Gastric Bands. The Adjustable Gastric Bands segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the upcoming forecasted years according to precision business insights. Based on end user, the global gastric bands market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Gastric band devices are majorly used by surgeons to treat obesity and it reduces the consumption of food. Obesity rates is continuously increasing for all population groups across the world over the last several decades due to unhealthy eating habits, increasing consumption of alcohol and cigarette, and poor lifestyle. For instance, in 2015-16, in Unites States, 39.8% of adults aged 20 and over were obese (including 7.7% with severe obesity) and that another 31.8% were overweight. Globally, about 13% of the world’s population were obese in 2016. The increasing adoption of minimally invasive technologies and change in lifestyle and dietary habits that increases obesity are the major factors that are driving the growth of the market. Moreover, increasing per capita expenditure on healthcare in emerging countries and initiatives by the government bodies in healthcare infrastructure development are expected to boost the growth of the market.
Key Development:
In Aug 2022, ReShape Lifescience received FDA 510(k) clearance for the GIBI HD calibration tubes for use in gastric and bariatric procedures.